LT2121636T - Piperazinilo ir diazepanilo benzamido darinių gamybos būdas - Google Patents

Piperazinilo ir diazepanilo benzamido darinių gamybos būdas

Info

Publication number
LT2121636T
LT2121636T LTEP07855037.3T LT07855037T LT2121636T LT 2121636 T LT2121636 T LT 2121636T LT 07855037 T LT07855037 T LT 07855037T LT 2121636 T LT2121636 T LT 2121636T
Authority
LT
Lithuania
Prior art keywords
piperazinyl
preparation
benzamide derivatives
diazepanyl benzamide
diazepanyl
Prior art date
Application number
LTEP07855037.3T
Other languages
English (en)
Inventor
Anusuya Choudhury
Jeffrey S. Grimm
Kirk L. Sorgi
David Palmer
Jing Liu
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of LT2121636T publication Critical patent/LT2121636T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
LTEP07855037.3T 2006-12-14 2007-12-10 Piperazinilo ir diazepanilo benzamido darinių gamybos būdas LT2121636T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87000306P 2006-12-14 2006-12-14
PCT/US2007/086936 WO2008076685A2 (en) 2006-12-14 2007-12-10 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives

Publications (1)

Publication Number Publication Date
LT2121636T true LT2121636T (lt) 2017-05-10

Family

ID=39387172

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP07855037.3T LT2121636T (lt) 2006-12-14 2007-12-10 Piperazinilo ir diazepanilo benzamido darinių gamybos būdas

Country Status (33)

Country Link
US (2) US7893257B2 (lt)
EP (1) EP2121636B1 (lt)
JP (2) JP5385150B2 (lt)
KR (1) KR101462891B1 (lt)
CN (1) CN101605767A (lt)
AR (1) AR064358A1 (lt)
BR (1) BRPI0721088B8 (lt)
CA (2) CA2672661C (lt)
CL (1) CL2007003637A1 (lt)
CO (1) CO6210827A2 (lt)
CR (1) CR10928A (lt)
CY (1) CY1118814T1 (lt)
DK (1) DK2121636T3 (lt)
EA (1) EA200970583A1 (lt)
EC (1) ECSP099405A (lt)
ES (1) ES2620818T3 (lt)
HR (1) HRP20170621T1 (lt)
HU (1) HUE032761T2 (lt)
IL (2) IL199309A0 (lt)
LT (1) LT2121636T (lt)
MX (1) MX2009006472A (lt)
MY (1) MY147320A (lt)
NO (1) NO344305B1 (lt)
NZ (1) NZ577603A (lt)
PH (1) PH12012502236B1 (lt)
PL (1) PL2121636T3 (lt)
PT (1) PT2121636T (lt)
RS (1) RS55866B1 (lt)
SG (1) SG177207A1 (lt)
SI (1) SI2121636T1 (lt)
TW (1) TW200846004A (lt)
WO (1) WO2008076685A2 (lt)
ZA (1) ZA200904894B (lt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0324159D0 (en) 2003-10-15 2003-11-19 Glaxo Group Ltd Novel compounds
EP1976828B1 (en) 2005-12-29 2016-12-21 Celtaxsys, Inc. Diamine derivatives as inhibitors of leukotriene a4 hydrolase
LT2121636T (lt) * 2006-12-14 2017-05-10 Janssen Pharmaceutica N.V. Piperazinilo ir diazepanilo benzamido darinių gamybos būdas
US20090170869A1 (en) 2007-09-06 2009-07-02 Desmond John Best Piperazine derivative having affinity for the histamine h3 receptor
EA017919B1 (ru) 2007-12-10 2013-04-30 Новартис Аг Производные пиразин-2-карбоксамида для лечения заболеваний, которые поддаются лечению путем блокирования эпителиальных натриевых каналов
US8383657B2 (en) 2007-12-21 2013-02-26 Abbott Laboratories Thiazolylidine urea and amide derivatives and methods of use thereof
ES2864862T3 (es) 2013-03-12 2021-10-14 Celltaxis Llc Métodos de inhibición de la leucotrieno A4 hidrolasa
MX2015011678A (es) 2013-03-14 2016-07-08 Celtaxsys Inc Inhibidores de leucotrieno a4 hidrolasa.
CA2906086A1 (en) 2013-03-14 2014-09-25 Celtaxsys, Inc. Inhibitors of leukotriene a4 hydrolase
MX2015011677A (es) 2013-03-14 2016-07-08 Celtaxsys Inc Inhibidores de leucotrieno a4 hidrolasa.
CN108341792B (zh) * 2018-04-28 2021-09-17 苏州莱克施德药业有限公司 一种Volasertib中间体1-环丙基甲基哌嗪的制备方法
US10898484B2 (en) 2018-05-31 2021-01-26 Celltaxis, Llc Method of reducing pulmonary exacerbations in respiratory disease patients
CN113372245B (zh) * 2021-06-17 2023-01-13 仪征市海帆化工有限公司 一种n-苯甲酰基-o,o-对甲苯磺酰基-二乙醇胺的合成方法
CN119462566A (zh) * 2023-10-30 2025-02-18 安徽皓元药业有限公司 一种1-环丙基哌嗪的制备方法
KR102815002B1 (ko) 2023-12-06 2025-05-30 주식회사 삼현 모터 일체형 중공형 감속기의 냉각구조

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2525223A (en) 1948-05-25 1950-10-10 American Cyanamid Co Preparation of n-substituted piperazines
DE818805C (de) * 1948-08-02 1951-10-29 Rhone Poulenc Sa Verfahren zur Herstellung von am Stickstoff durch eine Alkylgruppe monosubstituierten Piperazinen
US3342816A (en) * 1965-06-01 1967-09-19 Lilly Co Eli Cyclopropylpiperazinoalkyl-phenothiazines
DE3542002A1 (de) * 1985-11-28 1987-06-04 Bayer Ag 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3605005A1 (de) * 1986-02-18 1987-08-20 Basf Ag Verfahren zur herstellung von n-methylpiperazin
US6011029A (en) 1996-02-26 2000-01-04 Bristol-Myers Squibb Company Inhibitors of farnesyl protein transferase
CA2235642C (en) * 1998-05-15 2007-11-13 Torcan Chemical Ltd. Processes for preparing sildenafil
EP1351946A2 (en) 2000-09-01 2003-10-15 Icos Corporation Materials and methods to potentiate cancer treatment
US6642226B2 (en) 2001-02-06 2003-11-04 Hoffman-La Roche Inc. Substituted phenyl-piperidine methanone compounds
DE10201240A1 (de) 2002-01-15 2003-07-24 Bayer Ag Substituierte Alkyluracile und ihre Verwendung
DE60330269D1 (de) * 2002-10-23 2010-01-07 Janssen Pharmaceutica Nv Piperazinyl- und diazapanylbenzamide und-benzothioamide
WO2005035534A1 (ja) * 2003-10-08 2005-04-21 Ono Pharmaceutical Co., Ltd. 複素ビシクロ環および複素トリシクロ環化合物およびその医薬
GB0324159D0 (en) * 2003-10-15 2003-11-19 Glaxo Group Ltd Novel compounds
WO2006042103A2 (en) 2004-10-05 2006-04-20 Axys Pharmaceuticals, Inc. Reversible inhibitors of cathepsin b
BRPI0519288A2 (pt) 2004-12-24 2009-01-06 Astrazeneca Ab compostos heterocÍclicos como antagonistas de ccr2b
FR2885616B1 (fr) * 2005-05-12 2007-06-22 Servier Lab Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PL1948607T3 (pl) 2005-09-16 2010-09-30 Janssen Pharmaceutica Nv Cyklopropyloaminy jako modulatory receptora histaminowego H3
NZ567357A (en) * 2005-10-31 2011-05-27 Janssen Pharmaceutica Nv Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
US7795426B2 (en) * 2005-10-31 2010-09-14 Janssen Pharmaceutica Nv Processes for the preparation of cyclopropyl-amide derivatives
LT2121636T (lt) * 2006-12-14 2017-05-10 Janssen Pharmaceutica N.V. Piperazinilo ir diazepanilo benzamido darinių gamybos būdas

Also Published As

Publication number Publication date
EA200970583A1 (ru) 2009-12-30
BRPI0721088B1 (pt) 2020-11-10
CR10928A (es) 2009-11-17
KR20090092319A (ko) 2009-08-31
AU2007334111A1 (en) 2008-06-26
MY147320A (en) 2012-11-30
JP2010513295A (ja) 2010-04-30
PL2121636T3 (pl) 2017-09-29
HUE032761T2 (en) 2017-10-30
CA2672661C (en) 2015-04-28
IL199309A0 (en) 2010-03-28
CY1118814T1 (el) 2018-01-10
TW200846004A (en) 2008-12-01
PH12012502236A1 (en) 2015-02-23
WO2008076685A2 (en) 2008-06-26
US8680273B2 (en) 2014-03-25
NO20092634L (no) 2009-09-08
US20080171870A1 (en) 2008-07-17
BRPI0721088B8 (pt) 2021-05-25
NO344305B1 (no) 2019-10-28
JP2013241453A (ja) 2013-12-05
BRPI0721088A2 (pt) 2014-02-25
CL2007003637A1 (es) 2008-07-18
EP2121636B1 (en) 2017-01-25
MX2009006472A (es) 2009-06-26
CO6210827A2 (es) 2010-10-20
CN101605767A (zh) 2009-12-16
SG177207A1 (en) 2012-01-30
KR101462891B1 (ko) 2014-11-19
CA2880932A1 (en) 2008-06-26
WO2008076685A3 (en) 2008-12-24
AR064358A1 (es) 2009-04-01
PT2121636T (pt) 2017-04-26
HRP20170621T1 (hr) 2017-07-28
SI2121636T1 (sl) 2017-06-30
ES2620818T3 (es) 2017-06-29
EP2121636A2 (en) 2009-11-25
JP5385150B2 (ja) 2014-01-08
US20110105752A1 (en) 2011-05-05
CA2672661A1 (en) 2008-06-26
ZA200904894B (en) 2010-09-29
NZ577603A (en) 2012-04-27
RS55866B1 (sr) 2017-08-31
ECSP099405A (es) 2009-07-31
PH12012502236B1 (en) 2015-02-23
DK2121636T3 (en) 2017-04-24
IL234893A (en) 2015-09-24
US7893257B2 (en) 2011-02-22

Similar Documents

Publication Publication Date Title
IL234893A (en) A process for making derivatives of piperazine and diazepanyl benzamide
IL198847A (en) Process for making 2-imino-thiazolidine-4-on and several such histories
IL192241A (en) A process for making 4 - (benzimidazolylmethylamino) - benzamides and their salts
IL202664A (en) Processes for Preparation of 3-Dihlomethyl-1-Methyl-1H-Pyrazole-4-Carbaldehyde and Intermediates
ZA200903533B (en) Process for the preparation of rosuvastatin
IL200873A0 (en) Novel benzamide derivatives and process for the preparation thereof
ZA200900551B (en) Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines
IL197877A (en) Uses of aminomethyl-4-imidazole derivatives for the preparation of medications and medications containing them
IL188919A (en) Process for the preparation of mandipropamide and its derivatives as well as its intermediates
IL197954A0 (en) Process for the preparation of imatinib and intermediates thereof
PL1844036T3 (pl) Sposób otrzymywania arypiprazolu
IL213474A0 (en) Processes for the preparation of cyclopropyl-amide derivatives
ZA201005282B (en) Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
EP2069307A4 (en) PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS
ZA200705880B (en) Process for the preparation of intermediates
IL200850A0 (en) Process for the preparation of entacapone and intermediates thereof
SI2044099T1 (sl) Postopek priprave S-fluorometil-6,9-difluoro-11-hidroksi-16-metil-17-propioniloksi-3-okso -androsta-1,4-dien-17-karbotioata in vmesnih spojin
ZA200804732B (en) Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
SI1940387T1 (sl) Postopek za stereoselektivno pripravo (-) halofenata in njegovih intermediatov
IL194737A0 (en) 2-alkenyl-3-aminothiophene derivatives and processes for the preparation thereof
PL1732556T3 (pl) Sposób wytwarzania 3-amino-8-(1-piperazynylo)-2H-1-benzopiran-2-onu oraz jego soli i hydratów
ZA200706203B (en) Processes and compounds for the preparation of substituted naphthylindole derivatives
HK1119677A (en) Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
ZA200901969B (en) Process for the preparation of ciclesonide and its crystal modification
ZA200803329B (en) Process for the stereoselective preparation of (-)-halofenate and intermediates thereof